RenalGuard Therapy for reduction in the incidence of Contrast-Associated AKI (CA-AKI) in at-risk patients

Status:

Topic prioritisation

Technology type:

Procedure

Decision:

Not prioritised

Prioritisation programme:

Guidelines

Reason for decision:

Not eligible for Health Technology Evaluation guidance

Rationale:

Prioritisation Board agreed that there does not appear to be a significant system need for the technology and that there is the potential for an increased budget impact compared with current clinical practice.

ID number:

2015

Email enquiries

If you have any queries please email ip@nice.org.uk

Timeline

Key events during the development of the guidance:

For further information on how we select topics for development, please see our page about topic prioritisation